Cargando…

Spinal or Intravenous Dexmedetomidine for Spinal Anesthesia with Chloroprocaine in Ambulatory Knee Arthroscopies: A Double-Blind Randomized Trial

PURPOSE: Chloroprocaine provides spinal anesthesia for day-case surgery lasting up to 40 minutes. Intravenous and spinal dexmedetomidine can prolong spinal anesthesia, but no data are available for the combination with chloroprocaine. This double-blind randomized controlled trial compares chloroproc...

Descripción completa

Detalles Bibliográficos
Autores principales: Breebaart, Margaretha B, Saerens, Lies, Branders, Jordi, Casaer, Sari, Sermeus, Luc, Van Houwe, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612665/
https://www.ncbi.nlm.nih.gov/pubmed/34849019
http://dx.doi.org/10.2147/LRA.S324876
_version_ 1784603490500214784
author Breebaart, Margaretha B
Saerens, Lies
Branders, Jordi
Casaer, Sari
Sermeus, Luc
Van Houwe, Patrick
author_facet Breebaart, Margaretha B
Saerens, Lies
Branders, Jordi
Casaer, Sari
Sermeus, Luc
Van Houwe, Patrick
author_sort Breebaart, Margaretha B
collection PubMed
description PURPOSE: Chloroprocaine provides spinal anesthesia for day-case surgery lasting up to 40 minutes. Intravenous and spinal dexmedetomidine can prolong spinal anesthesia, but no data are available for the combination with chloroprocaine. This double-blind randomized controlled trial compares chloroprocaine with spinal or intravenous dexmedetomidine regarding block characteristics, micturition, and discharge times. PATIENTS AND METHODS: After ethical approval and informed consent, 135 patients scheduled for knee arthroscopy were randomized to receive either 40mg spinal chloroprocaine (Chloro-group), 40mg chloroprocaine with 5 mcg spinal dexmedetomidine (Spinal Dex-group) or 40mg chloroprocaine with 0.5 mcg/kg IV dexmedetomidine (IV DEXgroup). Block characteristics, hemodynamic variables and the use of analgesics were registered. Voiding and discharge times were noted. A scoring system was used for micturition problems and sedation. Transient neurological symptoms (TNS) and other late side effects were evaluated after one week. RESULTS: Demographic data were similar between groups. Block onset times and intensity of motor block were comparable between groups. The time to L2 and Bromage 1 regression was prolonged in the SpinalDEx-group by approximately 30 minutes compared to the other groups (p < 0.01). First voiding as well as discharge from the hospital was prolonged in the Spinal Dex-group by approximately 40 minutes p < 0.01. There was no significant difference between groups regarding treatment of hypotension, sedation, micturition problems or the use of postoperative analgesics (P > 0.8). One patient experienced TNS. CONCLUSION: Intrathecal but not intravenous (0.5 mcg/kg) dexmedetomidine can prolong chloroprocaine (40mg) spinal anesthesia when surgery is expected to last over 40 minutes. Despite a similar incidence of adverse effects, this also led to a postponed hospital discharge time.
format Online
Article
Text
id pubmed-8612665
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-86126652021-11-29 Spinal or Intravenous Dexmedetomidine for Spinal Anesthesia with Chloroprocaine in Ambulatory Knee Arthroscopies: A Double-Blind Randomized Trial Breebaart, Margaretha B Saerens, Lies Branders, Jordi Casaer, Sari Sermeus, Luc Van Houwe, Patrick Local Reg Anesth Clinical Trial Report PURPOSE: Chloroprocaine provides spinal anesthesia for day-case surgery lasting up to 40 minutes. Intravenous and spinal dexmedetomidine can prolong spinal anesthesia, but no data are available for the combination with chloroprocaine. This double-blind randomized controlled trial compares chloroprocaine with spinal or intravenous dexmedetomidine regarding block characteristics, micturition, and discharge times. PATIENTS AND METHODS: After ethical approval and informed consent, 135 patients scheduled for knee arthroscopy were randomized to receive either 40mg spinal chloroprocaine (Chloro-group), 40mg chloroprocaine with 5 mcg spinal dexmedetomidine (Spinal Dex-group) or 40mg chloroprocaine with 0.5 mcg/kg IV dexmedetomidine (IV DEXgroup). Block characteristics, hemodynamic variables and the use of analgesics were registered. Voiding and discharge times were noted. A scoring system was used for micturition problems and sedation. Transient neurological symptoms (TNS) and other late side effects were evaluated after one week. RESULTS: Demographic data were similar between groups. Block onset times and intensity of motor block were comparable between groups. The time to L2 and Bromage 1 regression was prolonged in the SpinalDEx-group by approximately 30 minutes compared to the other groups (p < 0.01). First voiding as well as discharge from the hospital was prolonged in the Spinal Dex-group by approximately 40 minutes p < 0.01. There was no significant difference between groups regarding treatment of hypotension, sedation, micturition problems or the use of postoperative analgesics (P > 0.8). One patient experienced TNS. CONCLUSION: Intrathecal but not intravenous (0.5 mcg/kg) dexmedetomidine can prolong chloroprocaine (40mg) spinal anesthesia when surgery is expected to last over 40 minutes. Despite a similar incidence of adverse effects, this also led to a postponed hospital discharge time. Dove 2021-11-20 /pmc/articles/PMC8612665/ /pubmed/34849019 http://dx.doi.org/10.2147/LRA.S324876 Text en © 2021 Breebaart et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Clinical Trial Report
Breebaart, Margaretha B
Saerens, Lies
Branders, Jordi
Casaer, Sari
Sermeus, Luc
Van Houwe, Patrick
Spinal or Intravenous Dexmedetomidine for Spinal Anesthesia with Chloroprocaine in Ambulatory Knee Arthroscopies: A Double-Blind Randomized Trial
title Spinal or Intravenous Dexmedetomidine for Spinal Anesthesia with Chloroprocaine in Ambulatory Knee Arthroscopies: A Double-Blind Randomized Trial
title_full Spinal or Intravenous Dexmedetomidine for Spinal Anesthesia with Chloroprocaine in Ambulatory Knee Arthroscopies: A Double-Blind Randomized Trial
title_fullStr Spinal or Intravenous Dexmedetomidine for Spinal Anesthesia with Chloroprocaine in Ambulatory Knee Arthroscopies: A Double-Blind Randomized Trial
title_full_unstemmed Spinal or Intravenous Dexmedetomidine for Spinal Anesthesia with Chloroprocaine in Ambulatory Knee Arthroscopies: A Double-Blind Randomized Trial
title_short Spinal or Intravenous Dexmedetomidine for Spinal Anesthesia with Chloroprocaine in Ambulatory Knee Arthroscopies: A Double-Blind Randomized Trial
title_sort spinal or intravenous dexmedetomidine for spinal anesthesia with chloroprocaine in ambulatory knee arthroscopies: a double-blind randomized trial
topic Clinical Trial Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612665/
https://www.ncbi.nlm.nih.gov/pubmed/34849019
http://dx.doi.org/10.2147/LRA.S324876
work_keys_str_mv AT breebaartmargarethab spinalorintravenousdexmedetomidineforspinalanesthesiawithchloroprocaineinambulatorykneearthroscopiesadoubleblindrandomizedtrial
AT saerenslies spinalorintravenousdexmedetomidineforspinalanesthesiawithchloroprocaineinambulatorykneearthroscopiesadoubleblindrandomizedtrial
AT brandersjordi spinalorintravenousdexmedetomidineforspinalanesthesiawithchloroprocaineinambulatorykneearthroscopiesadoubleblindrandomizedtrial
AT casaersari spinalorintravenousdexmedetomidineforspinalanesthesiawithchloroprocaineinambulatorykneearthroscopiesadoubleblindrandomizedtrial
AT sermeusluc spinalorintravenousdexmedetomidineforspinalanesthesiawithchloroprocaineinambulatorykneearthroscopiesadoubleblindrandomizedtrial
AT vanhouwepatrick spinalorintravenousdexmedetomidineforspinalanesthesiawithchloroprocaineinambulatorykneearthroscopiesadoubleblindrandomizedtrial